$4.78 -0.04 (-0.83%)
11/27/2009 12:55 PM

SenoRx, Inc. (SENO)

CAPS Rating: 4 out of 5

The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.

Results 1 - 3 of 3

Recs

0
Member Avatar JhansiKiRani (54.17) Submitted: 6/27/2007 11:44:42 AM : Outperform Start Price: $9.83 SENO Score: -28.81

It's already outeperformed S & P once.

Recs

0
Member Avatar jhe2jhe (25.65) Submitted: 9/27/2007 7:01:37 PM : Outperform Start Price: $8.38 SENO Score: -18.07

Great startup will do well. Very good business lan in a much needed area with outstanding products

Recs

0
Member Avatar janvandebong (71.41) Submitted: 1/3/2008 12:35:24 PM : Outperform Start Price: $8.50 SENO Score: -22.29

I wouldn't buy it, I like p/e ratios too much - but I could see this becoming an intuitive surgical-type stock eventually. It's growing, paying off debt, & this price seems to be a reasonable jumping off point.

Results 1 - 3 of 3

Featured Broker Partners